Harvard Bioscience, Inc. (HBIO) Reports Q2 Earnings of $0.06
Tweet Send to a FriendGet Alerts HBIO Hot Sheet
Price: $5.20 -0.57%
EPS Growth %: -11.1%
Financial Fact:
Cost of product revenues: 13.82M
Today's EPS Names:
LBIX, ESEA, ISS, More
EPS Growth %: -11.1%
Financial Fact:
Cost of product revenues: 13.82M
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade HBIO Now!
Harvard Bioscience, Inc. (NASDAQ: HBIO) reported Q2 EPS of $0.06, versus $0.08 reported last year. Revenue for the quarter came in at $28.5 million versus the consensus estimate of $27.1 million.
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Kohls Corp. (KSS) Tops Q1 EPS by 8c; Comps Down 1.9%; Guides Q2
- Hollsys (HOLI) Tops Q3 EPS by 1c; Lowers FY13 Outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
